BOTOX® Open-Label Treatment in Pediatric Upper Limb Spasticity

Completed · Phase 3

Conditions studied: Pediatrics, Muscle Spasticity, Cerebral Palsy, Stroke

In brief

This study will evaluate the long-term safety of BOTOX® (botulinum toxin Type A) for the treatment of pediatric upper limb spasticity.

Key facts

Study ID
NCT01603615
Run by
Allergan
People needed
220
Starts
2012-10-30
Expected to finish
2018-09-03
Last updated by the study team
2019-08-21

Who can join

Age: 2 and older, up to 17. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.